Abstract
Ozanimod (Zeposia (R)) is the first sphingosine-1-phosphate receptor (S1PR) modulator to be approved for the treatment of adults with moderately to se......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
